12:00 AM
 | 
Nov 18, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Impavido miltefosine regulatory update

Paladin said FDA delayed by 3 months the PDUFA date for an NDA for Impavido miltefosine to treat cutaneous, mucosal and visceral leishmaniasis. The new date is March 19, 2014; it was Dec. 19. Paladin said it submitted revisions on...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >